Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$585K Sell
12,136
-4,536
-27% -$232K 0.02% 204
2026
Q2
$874K Sell
16,672
-11,267
-40% -$596K 0.03% 166
2026
Q1
$1.54M Sell
27,939
-21
-0.1% -$1.14K 0.06% 116
2025
Q4
$1.37M Sell
27,960
-444
-2% -$20.7K 0.05% 129
2025
Q3
$1.23M Buy
+28,404
New +$1.11M 0.05% 136
2020
Q1
– Sell
-3,470
Closed -$204K – 255
2019
Q4
$204K Buy
+3,470
New +$193K 0.02% 261

Other funds holding GSK

Rockland Trust's GSK Position: Q3 2026 in Review

Rockland Trust reduced its GSK (GSK) stake by 27% in Q3 2026, selling an estimated $232K and leaving 12,136 shares worth $585K. The position accounts for 0.02% of the portfolio, ranked #204.

Rockland Trust first reported a position in GSK in Q4 2019 and has held it in 6 quarters since. The position peaked at $1.54M in Q1 2026. 854 funds tracked by Wall St. Rank hold GSK as of Q3 2026.

  • Rockland Trust held 12,136 shares of GSK worth $585K as of Q3 2026.
  • Rockland Trust sold 4,536 GSK shares in Q3 2026, an estimated $232K.
  • GSK made up 0.02% of Rockland Trust's portfolio in Q3 2026, its #204 holding.
  • Rockland Trust first reported a position in GSK in Q4 2019 and has held it in 6 quarters since.
  • Rockland Trust's GSK position peaked at $1.54M in Q1 2026.
  • 854 funds tracked by Wall St. Rank held GSK as of Q3 2026.

Based on Rockland Trust's 13F filing for Q3 2026, filed 5 Oct 2026.